Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Deals

Grail spins back into Illumina for $8bn
Two weeks after filing to go public, Grail has instead accepted an $8bn acquisition offer from Illumina, which had spun off the cancer diagnostics technology developer five years ago.
WM Motor wins over investors for $1.47bn series D
Baidu, Tencent and China Minmetals-backed electric vehicle producer WM Motor has raised $1.47bn in a series D round to support R&D, marketing and sales activities.
Acesso Digital taps into $107m series B
SoftBank’s Latin America Fund and General Atlantic have co-led a $107m series B round for Acesso Digital, a facial recognition technology developer that will use the money to scale.
Playco starts funding game with $100m
Digital Garage has helped launch mobile gaming platform Playco with a $100m series A round and a valuation of more than $1bn.
Leyan locks in series C2
The Kunlun-backed customer engagement software provider has closed its series C round at about $44m, having raised a similar amount in series C1 funding four months ago.
K Wah helps Hrain close series B-plus
K Wah Group’s subsidiary has taken part in the tumour therapy and drug developer’s $29.3m round, which came a year after its $28m series B round.

News Continued

Oncocross smiles with new round
Seeq adds Cisco to series B round
Baijiayun basks in $26.3m series B
Cash Capital was among the investors for Baijiayun, a Mooc platform whose shareholders also include Xiaodu Huyu, Huatu Education and BaishanCloud.
Chime rings $485m funding bell
Chime has increased its valuation nearly tenfold in 18 months and is worth $14.5bn following a $485m series F round that included existing shareholder Access Industries.
Roche fires up $448m Inflazome acquisition
Novartis-backed Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.
Compass navigates IPO
Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.

Editor's Picks

Amwell rams its way to $742m IPO
The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Snowflake hits public markets in $3.36bn IPO
Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.
Opendoor welcomes reverse merger
Lennar, SoftBank, Access Industries and Alphabet are set to score exits from the real estate transaction manager, valued at $4.8bn in the deal.
Zwift rides momentum to $450m
Amazon Alexa Fund and Specialized Bicycle Components vehicle Zone 5 Ventures helped the social exercise platform raise money at a valuation above $1bn.
test reg

Login